Close

Invivo Therapeutics (NVIV) to Commence Clinical Study of Neuro-Spinal Scaffold

March 23, 2017 8:09 AM EDT Send to a Friend
InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational Testing Authorization application to commence ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login